Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers

Backgrounds and aims: Migraine and inflammation are correlated. Coenzyme Q10 (CoQ10) as an anti-inflammatory agent has shown useful effects in other diseases. The present study aimed to assess the effect of CoQ10 supplementation on inflammation and clinical features of migraine. Methods: This randomized double-blind placebo-controlled clinical trial was conducted among 45 non-menopausal women aged 18–50 years, diagnosed for episodic migraine according to the International Headache Society. After one month run-in period, subjects received CoQ10 (400 mg/day CoQ10, n = 23) or placebo (wheat starch, n = 22) for three months. All the patients got prophylactic medication too. Serum CoQ10 concentration, Calcitonin gene-related peptide (CGRP), interleukin (IL)-6, IL-10 and tumor necrosis factor-α (TNF-α) were measured at the beginning and end of the study. Results: CoQ10 supplementation reduced CGRP and TNF-α significantly (p = 0.011 and p = 0.044, respectively), but there were no significant differences in serum IL-6 and IL-10 between the two groups. Significant increase in serum CoQ10 levels was evident with CoQ10 therapy (P < 0.001). A significant improvement was found in frequency (p = 0.018), severity (p = 0.001) and duration (p = 0.012) of migraine attacks in CoQ10 group compared to placebo. Conclusion: CoQ10 supplementation may decrease CGRP and TNF-α with no favorable effects on IL-6 and IL-10 in patients with migraine.

[1]  L. Edvinsson.  The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine , 2017, Headache.

[2]  M. Salehi,et al.  Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial , 2017, Acta Neurologica Belgica.

[3]  M. Behzadifar,et al.  The Prevalence of Migraine in Iran: A Systematic Review and Meta-Analysis , 2016, Iranian Red Crescent medical journal.

[4]  M. Mohammadshahi,et al.  Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial , 2016, Journal of the American College of Nutrition.

[5]  T. Pringsheim,et al.  Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use , 2016, Headache.

[6]  A. Mauskop,et al.  Nutraceuticals in Acute and Prophylactic Treatment of Migraine , 2016, Current Treatment Options in Neurology.

[7]  Yi-Chia Huang,et al.  Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial , 2015, Nutrition Journal.

[8]  H. Sadeghi-Bazargani,et al.  Randomization: Techniques and Software-aided Implementation in Medical Studies , 2015 .

[9]  H. Abdollahzad,et al.  Effects of Coenzyme Q10 Supplementation on Inflammatory Cytokines (TNF-α, IL-6) and Oxidative Stress in Rheumatoid Arthritis Patients: A Randomized Controlled Trial. , 2015, Archives of medical research.

[10]  Z. Asemi,et al.  The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome , 2015, European Journal of Nutrition.

[11]  E. Sabina,et al.  The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10 , 2015, Cell Biology and Toxicology.

[12]  L. Edvinsson.  CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. , 2015, British journal of clinical pharmacology.

[13]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[14]  Maha A E Ahmed,et al.  Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats , 2015, Immunopharmacology and immunotoxicology.

[15]  S. Eghtesadi,et al.  Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial , 2015, Nutritional neuroscience.

[16]  P. Goadsby,et al.  CGRP Mechanism Antagonists and Migraine Management , 2015, Current Neurology and Neuroscience Reports.

[17]  J. Khubchandani,et al.  Vascular biomarkers in migraine , 2015, Cephalalgia : an international journal of headache.

[18]  C. Kruuse,et al.  Endothelial Function in Migraine With Aura – A Systematic Review , 2015, Headache.

[19]  G. Comi,et al.  Riboflavin and migraine: the bridge over troubled mitochondria , 2014, Neurological Sciences.

[20]  C. Yen,et al.  Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial , 2013, Nutrition Journal.

[21]  H. Jin,et al.  [Effect of coenzyme Q10 on the expression of tumor necrosis factor-α and interleukin-10 in gingival tissue of experimental periodontitis in rats]. , 2013, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[22]  P. Martínez-Camblor,et al.  Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine , 2013, Neurology.

[23]  H. Hardison,et al.  Mitochondrial dysfunction in migraine. , 2013, Seminars in pediatric neurology.

[24]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[25]  J. Ochoa,et al.  Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise , 2012, European Journal of Nutrition.

[26]  S. Silberstein,et al.  Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.

[27]  E. Uzar,et al.  Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. , 2011, European review for medical and pharmacological sciences.

[28]  M. Donnino,et al.  Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock , 2011, Critical care.

[29]  S. Powers,et al.  A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine , 2011, Cephalalgia : an international journal of headache.

[30]  Shereen M. Refaie,et al.  Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. , 2010, Toxicology.

[31]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[32]  Patrice D Cani,et al.  Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. , 2009, Biochemical pharmacology.

[33]  S. Silberstein.  Preventive Migraine Treatment , 2009, Neurologic clinics.

[34]  P. Shanthi,et al.  Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles , 2009, Breast Cancer Research and Treatment.

[35]  A. Galinier,et al.  Coadministration of Coenzyme Q prevents Rosiglitazone-induced adipogenesis in ob/ob mice , 2009, International Journal of Obesity.

[36]  G. Rimbach,et al.  In Vitro Effects of the Reduced Form of Coenzyme Q10 on Secretion Levels of TNF-α and Chemokines in Response to LPS in the Human Monocytic Cell Line THP-1 , 2008, Journal of clinical biochemistry and nutrition.

[37]  J. Fedačko,et al.  Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study , 2007, Acta cardiologica.

[38]  S. Powers,et al.  Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine , 2007, Headache.

[39]  A. Shao,et al.  Risk assessment for coenzyme Q10 (Ubiquinone). , 2006, Regulatory toxicology and pharmacology : RTP.

[40]  P. Durham.  Calcitonin Gene‐Related Peptide (CGRP) and Migraine , 2006, Headache.

[41]  H. Ikematsu,et al.  Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. , 2006, Regulatory toxicology and pharmacology : RTP.

[42]  I. Fidan,et al.  The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine , 2006, Journal of Neuroimmunology.

[43]  G. D'andrea,et al.  Plasma Cytokine Levels in Migraineurs and Controls , 2005, Headache.

[44]  G. Coppola,et al.  Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial , 2005, Neurology.

[45]  S. Powers,et al.  Carnitine Palmityltransferase II (CPT2) Deficiency and Migraine Headache: Two Case Reports , 2003, Headache.

[46]  S. Silberstein,et al.  Open Label Trial of Coenzyme Q10 as A Migraine Preventive , 2002, Cephalalgia : an international journal of headache.

[47]  B. Barbiroli,et al.  Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache , 2001, Brain Research Bulletin.

[48]  G. Comi,et al.  Cytokines and immunity in multiple sclerosis: the dual signal hypothesis , 2000, Journal of Neuroimmunology.

[49]  M. Jafarabadi,et al.  Effects of Coenzyme Q10 Supplementation on Inflammatory Cytokines (TNF-α, IL-6) and Oxidative Stress in Rheumatoid Arthritis Patients: A Randomized Controlled Trial. , 2015, Archives of medical research.

[50]  D. Moher,et al.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.

[51]  A. Panagariya.  Elevation of CSF Tumor Necrosis Factor α Levels in New Daily Persistent Headache and Treatment Refractory Chronic Migraine , 2008 .

[52]  B. Ainsworth,et al.  Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ) - Short and long forms , 2005 .